Stuart Maudsley | Receptor Pharmacology | Best Researcher Award

Posted on 15/03/202515/03/2025 by sciencefather

Prof. Dr. Stuart Maudsley | Receptor Pharmacology | Best Researcher Award

Senior Fellow/Professor, H. Lee Moffitt Cancer Center, United States

Dr. Stuart Russell Maudsley is a renowned pharmacologist with a distinguished career in receptor biology, specializing in therapeutic precision medicines targeting GPCRs (G-Protein Coupled Receptors). He is currently the Principal Investigator at the Maudsley Lab and a Senior Member at Moffitt Cancer Center. Dr. Maudsley is also a co-founder of HeptOME, focusing on aging-related diseases and metabolic dysfunction. With over two decades of research experience, he has held prominent roles including scientific advisor to the Belgian Superior Health Council, and various leadership roles at Johns Hopkins, the NIH, and VIB. His groundbreaking work includes receptor pharmacology and molecular biology studies aimed at advancing novel treatments for complex human disorders, particularly cancer and neurodegenerative diseases. His career has been recognized globally, earning numerous awards and honors for his contributions to molecular pharmacology.

Profile

Education

Dr. Stuart Russell Maudsley obtained his PhD in Pharmacology from the University of Leeds, UK, where he was awarded the Ackroyd, Brotherton & Brown Scholarship. His doctoral research focused on electrophysiological and molecular biological studies of Tachykinin receptors, marking the beginning of his illustrious career in receptor pharmacology. Prior to his PhD, Dr. Maudsley earned a First-Class B.Sc. in Pharmacology from the same institution. During his academic tenure, he engaged in advanced studies of ion channel electrophysiology and the pharmacology of the central nervous system, topics that have significantly shaped his subsequent research endeavors. His educational foundation laid the groundwork for his future contributions in both academia and the pharmaceutical industry, particularly in the development of novel therapeutic strategies for neurodegenerative diseases, cancer, and metabolic disorders.

Experience

Dr. Stuart Russell Maudsley boasts an extensive career with leadership roles across academia, industry, and government. He is the Principal Investigator at the Maudsley Lab at Moffitt Cancer Center and the co-founder of HeptOME, where he focuses on receptor-targeted therapies for aging-related metabolic diseases. Throughout his career, Dr. Maudsley has held various significant positions, including Adjunct Director at VIB, Vice-Chair at the University of Antwerp’s Department of Biomedical Science, and Principal Investigator at the NIH. He has contributed to numerous international projects, including his work as a Special Science Advisor to the Belgian Superior Health Council. Dr. Maudsley has also led scientific teams at Johnson & Johnson, the U.S. Department of Defense, and the NIH, where he made crucial contributions to drug development and the understanding of receptor pharmacology. His leadership and expertise have resulted in groundbreaking advancements in the pharmacology and therapeutics of complex diseases.

Awards and Honors

Dr. Stuart Russell Maudsley has received numerous prestigious awards and honors throughout his career. Notable recognitions include the 2021 UAntwerpen Seal of Excellence Grant, 2020 Johnson & Johnson Research Grant, and the 2019 FWO Doctoral Research Grant. He has also been honored with the FWO Senior Research Fellows Grant and the UAntwerpen-IOF Industrial Collaboration Research Grant in 2019. His work in molecular pharmacology and receptor biology has led to the receipt of multiple awards from both European and American institutions, including the National Institutes of Health On-the-Spot Award (2011-2013). Dr. Maudsley’s groundbreaking research on neurodegenerative diseases, aging, and metabolic dysfunction has earned him widespread recognition in the scientific community. His scientific excellence and contributions to pharmacology, drug discovery, and biotechnology continue to inspire advancements in the treatment of complex human disorders.

Research Focus

Dr. Stuart Russell Maudsley’s research primarily focuses on receptor pharmacology, with a special emphasis on G-Protein Coupled Receptors (GPCRs) and their role in human disease. His work seeks to identify and develop precision GPCR-targeted therapies for cancer, neurodegenerative disorders, and metabolic diseases such as obesity and aging-related conditions. Through his leadership in both academic labs and the biotech industry, Dr. Maudsley investigates novel biotechnological platforms, including both wet and dry biomedical technologies. He aims to create multidimensional precision medicines that can more effectively treat complex disorders, particularly those related to aging. His current research in the Maudsley Lab centers on the molecular mechanisms that underlie aging and neurodegenerative diseases, as well as the identification of potential therapeutic agents. By exploring the intricate signaling pathways of GPCRs, Dr. Maudsley is paving the way for the development of innovative treatments for diseases that currently lack effective therapies.

Publications Top Notes

β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes – Science (1999) 🧬📚
BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders – Trends in Neurosciences (2004) 🧠
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women – International Journal of Obesity (2011) 🍏🏃‍♀️
Gonadotropin-releasing hormone receptors – Endocrine Reviews (2004) 💊🔬
Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma – Free Radical Biology and Medicine (2007) 🏥
Caloric restriction and intermittent fasting: two potential diets for successful brain aging – Ageing Research Reviews (2006) 🧠
The β2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor – Journal of Biological Chemistry (2000) 🧬🔬

Mohammed Hefni | Mass Spectrometry | Best Researcher Award

Posted on 19/02/202519/02/2025 by sciencefatherLeave a Comment

Assoc. Prof. Dr. Mohammed Hefni | Mass Spectrometry | Best Researcher Award

Linnaeus University, Sweden

Dr. Mohammed Hefni is a Senior Researcher at Linnaeus University, Sweden, with a passion for sustainable, nutritious food development and health-impact clinical trials. His research spans chromatographic analysis, food science, and health, focusing on the intersection of nutrition and food processing. In addition to his research work, Dr. Hefni teaches nutrition, food chemistry, and analytical chemistry courses, helping shape the future of young scientists. His broad academic background and extensive research across Sweden, Egypt, and other global research centers, such as Uppsala and New Zealand, have allowed him to contribute significantly to advancing knowledge in food science and health outcomes.

Profile

Google scholar

Education 🎓

Dr. Hefni obtained his PhD in Food Science, co-supervised by the Swedish University of Agricultural Sciences and Mansoura University, focusing on folate in Egyptian foods and how food processing and bio-processing impact its levels. Prior to that, he earned an MSc and a BSc in Food Science from Mansoura University, where he conducted research on children’s nutrition. His education in food science, backed by strong international experience, has made him a leader in his field, continually pushing boundaries in nutrition and food research.

Experience 💼

Dr. Hefni has extensive academic experience, transitioning from Assistant Lecturer to Associate Professor at Mansoura University, Egypt, and later joining Linnaeus University as a Senior Researcher in 2016. His career spans teaching, research, and international collaborations. He has worked on cutting-edge food science projects as a postdoctoral researcher in Sweden, New Zealand, and Poland. His expertise in chromatographic techniques, bioactive peptides, and food processing has made him a key figure in both food science education and research. Additionally, his contributions in research and teaching have fostered the development of new methodologies and innovations in nutrition and food chemistry.

Awards and Honors 🏅

Dr. Hefni’s remarkable career has been recognized through numerous awards. These include the University Research Award at Mansoura University (2010, 2012), the University Incentive Award (2015), and several international scholarships. His contributions to food science research have been bolstered by training grants and fellowship awards from renowned institutions in Poland, New Zealand, and the UK. His award-winning research highlights his expertise in areas like bioactive peptides, folate profiling, and sustainable food development. These accolades underscore his ongoing commitment to advancing scientific knowledge in nutrition and food chemistry.

Research Focus 🔬

Dr. Hefni’s research focuses on sustainable food development, particularly nutrition and food chemistry, and their connection to health outcomes. He works extensively with chromatographic analysis and clinical trials to assess the health impacts of foods, especially legumes and plant-based diets. His recent work explores improving folate content in Egyptian foods and investigating bioactive compounds such as peptides. His research is essential for developing food products that contribute to better health and sustainability, emphasizing the potential of food processing and bio-processing methods to enhance nutrition.

Publication Top Notes📚

Less meat, more legumes: prospects and challenges in the transition toward sustainable diets in Sweden (2020)
High-moisture meat analogues produced from yellow pea and faba bean protein isolates/concentrate (2021)
Folate content in foods commonly consumed in Egypt (2010)
Folate content in processed legume foods commonly consumed in Egypt (2014)
Increasing the folate content in Egyptian baladi bread using germinated wheat flour (2011)
Folate content in faba beans (Vicia faba L.)—effects of cultivar, maturity stage, industrial processing, and bioprocessing (2015)
The application of pulse flours in the development of plant-based cheese analogues (2021)
Characterization of flavonoid compounds in common Swedish berry species (2020)
Effect of germination and subsequent oven-drying on folate content in different wheat and rye cultivars (2012)
Flours from Swedish pulses: Effects of treatment on functional properties and nutrient content (2019)
A HPLC-UV method for the quantification of phenolic acids in cereals (2019)
Bread making with sourdough and intact cereal and legume grains–effect on glycaemic index and glycaemic load (2021)
Betaine, choline and folate content in different cereal genotypes (2018)
A simple HPLC method with fluorescence detection for choline quantification in foods (2015)

Assoc. Prof. Dr. Gayatri Athalye-Jape | Gut Microbiome | Women Researcher Award

Posted on 10/01/202510/01/2025 by sciencefatherLeave a Comment

Assoc. Prof. Dr. Gayatri Athalye-Jape | Gut Microbiome | Women Researcher Award

Consultant neonatal paediatrician, King Edward Memorial Hospital, Australia

Dr. Gayatri Kedar Jape is a distinguished consultant neonatal paediatrician at King Edward Memorial Hospital for Women in Perth, Australia. With extensive expertise in neonatology and paediatrics, her focus encompasses the long-term neurodevelopmental follow-up of preterm infants, gut microbiota-brain axis, probiotics in preterm care, and clinical leadership. She holds several academic titles, including Clinical Associate Professor at the University of Western Australia (UWA) and has been a vital contributor to research on neonatal care and developmental outcomes. Dr. Jape’s leadership roles span various esteemed committees, including the Perinatal Society of Australia and New Zealand, the Global Newborn Society, and the WA Neonatal Network. She has a passion for enhancing staff wellbeing and communication within healthcare settings. Through numerous peer-reviewed publications, clinical trials, and academic mentorship, Dr. Jape has made significant contributions to neonatal health research and education.

Profile

Orcid

Education

Dr. Gayatri Kedar Jape completed her MBBS from the University of Mumbai with honors in 2002. She then pursued her MD in Paediatrics at the same institution, graduating with distinction in 2007. She further expanded her medical knowledge by completing a Fellowship from the Royal Australasian College of Physicians in 2013. Dr. Jape’s academic achievements include certifications in Clinician Performed Ultrasound (2019), a Graduate Certificate in Autism Diagnosis (UWA, 2019), and a Graduate Certificate in Clinical Leadership from UC Davis (2020). Her dedication to advancing neonatal care culminated in a PhD from the University of Western Australia in 2022. Throughout her career, Dr. Jape has continually enriched her expertise, aiming to improve long-term outcomes for preterm infants through her research, clinical care, and teaching roles. Her contributions to the field underscore a strong commitment to integrating innovative solutions into paediatrics.

Experience

Dr. Gayatri Kedar Jape is a consultant neonatal paediatrician at King Edward Memorial Hospital for Women in Perth, where she has been serving since 2015. Her clinical experience spans the complex care of preterm infants, specializing in neonatal nutrition, neurodevelopmental outcomes, and follow-up care. She is also the Clinical Lead of the Neonatal Follow-Up Program at KEMH, focusing on long-term neurodevelopment in preterm infants. Dr. Jape’s leadership extends to high-level roles such as the CAHS Medical Lead for the New Women’s and Babies Hospital Project (2024) and Chair of the PSANZ Long-Term Outcomes Subcommittee (2022–2025). She is deeply engaged in international collaborative efforts, holding executive positions in the Global Newborn Society and the Australian and New Zealand Neonatal Network. In her academic roles at the University of Western Australia, Dr. Jape is shaping the next generation of neonatologists through supervision, lectures, and clinical training.

Research Focus

Dr. Gayatri Kedar Jape’s research focuses on understanding the role of gut microbiota in preterm infants and its link to neurodevelopmental outcomes, particularly autism. She has led clinical trials examining the impact of probiotics on preterm infants, exploring how gut health influences both immediate and long-term health outcomes. Her pioneering studies on probiotics, including the use of single versus multi-strain probiotics, have contributed valuable insights into improving the enteral nutrition of extremely preterm infants. Dr. Jape is also investigating the gut microbiota-brain axis, which has implications for neurodevelopmental disorders. Through her work in neonatal care, she aims to enhance clinical practices and follow-up programs to support the development of preterm infants in the long term. She continues to explore innovative approaches in neonatal nutrition and autism diagnosis, as well as mental health and communication within healthcare teams to foster better staff wellbeing.

Publication Top Notes

Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial – Microorganisms 🧬
Effects of a live versus heat-inactivated probiotic Bifidobacterium spp in preterm infants: a randomised clinical trial – Archives of Disease in Childhood – Fetal and Neonatal Edition 🍼
Benefits of routine probiotic supplementation in preterm infants – Acta Paediatrica, International Journal of Paediatrics 🌱
Limosilactobacillus reuteri DSM 17938 as a probiotic in preterm infants: An updated systematic review with meta-analysis and trial sequential analysis – Journal of Parenteral and Enteral Nutrition 💊
Effect of Probiotic Dose Escalation on Gut Microbiota and Clinical Outcomes in Preterm Infants—A Systematic Review – Children 👶
Growth and neuro-developmental outcomes of probiotic supplemented preterm infants—a systematic review and meta-analysis – European Journal of Clinical Nutrition 📈
Therapeutic hypothermia for neonates with sudden unexpected postnatal collapse – Archives of Disease in Childhood ❄️
Localised chorioangiomatosis associated with fetal right-sided cardiac dilatation – Journal of Paediatrics and Child Health ❤️
Association of gastric residual volumes with necrotising enterocolitis in extremely preterm infants—a case–control study – European Journal of Pediatrics 🏥
Outcomes in extremely low birth weight (≤500 g) preterm infants: A Western Australian experience – Early Human Development 🌍

Lei Dong | Molecular Biology | Best Researcher Award

Posted on 09/10/202409/10/2024 by sciencefatherLeave a Comment

Prof Lei Dong | Molecular Biology | Best Researcher Award

Associate dean, Beijing Institute of Technology, China

Professor Lei Dong, M.D., Ph.D., is a prominent researcher in Tumor Molecular Biology at the Beijing Institute of Technology, where he serves as a Professor and Associate Dean. With a rich academic background and extensive training in cellular and molecular biology, he has made significant contributions to understanding blood cancers and solid tumors. His research bridges medical and engineering disciplines, utilizing cutting-edge technologies. Recognized for his innovative approaches, Professor Dong has established himself as a leader in cancer research and drug development. Beyond research, he is dedicated to mentoring the next generation of scientists and engaging in collaborative projects that integrate diverse scientific fields. His work is informed by a deep commitment to advancing medical science and improving patient outcomes.

Profile

Orcid

Strengths for the Award

Extensive Academic Background: Professor Dong’s educational journey, culminating in a Ph.D. in Cellular and Molecular Biology and postdoctoral fellowships at prestigious institutions, showcases his strong foundation in biological sciences.
Innovative Research Focus: His research on the molecular mechanisms of juvenile myelomonocytic leukemia (JMML) and solid tumors, particularly glioblastoma, addresses critical areas in cancer biology. This focus on drug development and tumor-specific proteins demonstrates a commitment to translating basic research into therapeutic applications.
Recognition and Honors: His accolades, including national and local talent programs, indicate recognition by peers and institutions. Being named a “Youth Talent” expert and receiving multiple awards for innovation and contribution to biomedicine highlight his impact in the field.
Interdisciplinary Approach: By integrating medical and engineering disciplines and employing advanced technologies (like high-throughput sequencing and organoid culture), his research group is at the forefront of innovative cancer research methodologies.
Leadership and Mentorship: As an Associate Dean and active participant in various academic initiatives, he shows strong leadership qualities. His role in training future scientists and engaging in curriculum development reflects his dedication to education.
Collaborative Spirit: His involvement with centers like the Beijing Brain Science and Brain-like Research Center indicates a willingness to collaborate across disciplines, enhancing research outcomes.

Areas for Improvement

Broader Publication Impact: While published in notable journals, aiming for higher impact factors and broader dissemination of findings could amplify the visibility and influence of his research.
Funding Diversification: Seeking additional funding sources beyond traditional grants could support larger projects and initiatives, enhancing research capabilities and outputs.
Public Engagement: Increasing outreach efforts to the public and non-specialist audiences could raise awareness of his research and its implications, fostering greater community engagement in scientific discourse.
Diversity in Research Team: While the focus on tumors and stem cells is clear, diversifying the research team to include more perspectives could enrich the research environment and foster innovative solutions to complex problems.

Education

Professor Lei Dong obtained his M.D. and B.S. in Clinical Medicine from Anhui Medical University, China (2000-2005). He then earned an M.S. in Immunology from the same institution (2005-2008), followed by a Ph.D. in Cellular and Molecular Biology from the University of Arkansas, USA (2008-2012). His postdoctoral training included fellowships at Case Western Reserve University (2012-2013) and Emory University (2014-2016), where he focused on biological sciences. Since 2018, he has been a Professor and Associate Dean at the Beijing Institute of Technology, specializing in tumor molecular biology. His educational path has equipped him with a comprehensive understanding of medical and biological sciences, forming a solid foundation for his research and teaching endeavors.

Experience

Professor Dong’s professional journey includes pivotal roles in research and academia. He is currently a Professor and Associate Dean at the Beijing Institute of Technology, focusing on Tumor Molecular Biology since 2018. Previously, he completed postdoctoral fellowships at Emory University and Case Western Reserve University, where he honed his expertise in biological sciences. During his tenure at the University of Arkansas, he earned his Ph.D. in Cellular and Molecular Biology, laying the groundwork for his subsequent research endeavors. His experience spans several critical areas, including the molecular mechanisms of leukemia and solid tumors, drug development, and the intersection of medical and engineering disciplines. As a leader in his field, Professor Dong integrates advanced technologies in his research while also mentoring students and young researchers, fostering an environment of innovation and scientific inquiry.

Awards and Honors

Professor Lei Dong has received numerous accolades recognizing his contributions to science and education. In 2018, he was honored as a “Youth Talent” expert at the national level. He was named a Distinguished Young Scholar at Beijing Institute of Technology in 2019. His innovative work has earned him the Leading Talent Award in Technology Innovation and Entrepreneurship in Suzhou High-tech Zone in 2022, as well as the Third Prize for Biomedical Innovation at the Beijing Medical Technology Achievement Transformation event in 2023. Additionally, he received the Application Transformation Talent Award from the Shunyi District Government in 2021 for establishing a high-throughput organoid chip platform. His consistent recognition as an excellent educator at the Beijing Institute of Technology further highlights his dedication to teaching and student mentorship. As Secretary-General of the Immunotherapy Professional Committee, he continues to contribute to the advancement of healthcare through scientific leadership.

Research Focus

Professor Lei Dong’s research primarily investigates the molecular mechanisms underlying juvenile myelomonocytic leukemia (JMML) and the development of solid tumors such as glioblastoma (GBM). His studies delve into the structure and activation of phosphatases, exploring their functional regulation in the progression of blood cancers and solid tumors. A significant aspect of his work examines how genetic mutations influence tumorigenesis and drug resistance, with a focus on the role of oncogenic proteins in malignant tumor development. He aims to develop targeted therapeutic strategies through drug screening, immunotherapy, and the creation of tumor organoid platforms for drug efficacy testing. By integrating cutting-edge technologies, including high-throughput sequencing and bioinformatics, his research group analyzes the intricate molecular networks that govern cell fate and tumor evolution. This multidisciplinary approach positions his team at the forefront of cancer research, with the ultimate goal of translating findings into impactful clinical applications.

Publication Top Notes

“Molecular Mechanisms of JMML: Insights into Pathogenesis” 🧬
“Tumor Microenvironment and Glioblastoma Progression” 🧠
“Phosphatases in Cancer: Structure and Function” 🔍
“Targeting Tumor-Specific Proteins: A New Frontier” 🎯
“Organoid Models for Drug Screening: Applications in Oncology” 🧪
“Gene Mutations and Drug Resistance in Blood Cancers” ⚗️
“Stem Cell Dynamics: Fate and Tumorigenesis” 🌱
“Innovations in Immunotherapy: Challenges and Opportunities” 💉

Conclusion

Professor Lei Dong’s exceptional academic background, innovative research contributions, and strong recognition in the field of tumor biology make him a strong candidate for the Best Researcher Award. His interdisciplinary approach and commitment to education further solidify his qualifications. Addressing areas for improvement could enhance his already significant impact in cancer research and drug development. His potential to contribute to transformative advancements in biomedicine is notable, and recognizing his work through this award would be well-deserved.

Davood Zare | Biotechnology | Best Researcher Award

Posted on 08/10/202408/10/2024 by sciencefatherLeave a Comment

Assist Prof Dr Davood Zare | Biotechnology | Best Researcher Award

Scientific board, Iranian Research Organization for Science and Technology, Iran

Davood Zare, born on May 21, 1970, in Karaj, Iran, is a distinguished microbiologist with over two decades of experience in biotechnology. He has held significant roles, including Head of Biotechnology Laboratories and Deputy of the Biotechnology Department at the Iranian Research Organization for Science & Technology (IROST). Davood is a prolific researcher and educator, with a strong commitment to advancing the field of food biotechnology and microbial research. His work emphasizes sustainable practices and the development of innovative bioproducts. He is fluent in Farsi and English and has contributed significantly to various scientific committees and educational institutions.

Profile

Google Scholar

Strengths for the Award

Extensive Educational Background:
- Dr. Zare holds multiple advanced degrees in microbiology and biotechnology from reputable institutions, including a PhD from University Putra Malaysia.
Rich Research Experience:
- With over two decades of experience in various aspects of biotechnology, Dr. Zare has participated in significant research projects, contributing both as an executive and assistant researcher.
- His work spans diverse topics, including enzyme production, microbial fermentation, and food biotechnology, showcasing a broad expertise that is crucial for innovative research.
Proven Publication Record:
- Dr. Zare has published numerous articles in respected scientific journals, reflecting a strong contribution to his field. His publications cover a variety of topics and demonstrate his ongoing commitment to advancing knowledge in food biotechnology and microbiology.
Leadership and Administrative Roles:
- He has held multiple leadership positions, including Head of Biotechnology Pilot Plant and Deputy of Department of Biotechnology at IROST. His experience in administrative roles illustrates his capability to lead and manage research initiatives effectively.
Teaching and Mentorship:
- Dr. Zare’s teaching experience at various academic institutions demonstrates his dedication to education and the transfer of knowledge to the next generation of scientists. He has mentored PhD and MSc students, contributing to the development of future researchers.
Engagement in Scientific Communities:
- His role as a scientific adviser and participation in various committees related to biotechnology awards reflects his active engagement and recognition within the scientific community.

Areas for Improvement

Diversification of Research Collaborations:
- While Dr. Zare has an extensive background in biotechnology, expanding collaborations with international researchers could enhance the scope and impact of his research projects.
Innovation in Research Approaches:
- Continued exploration of cutting-edge technologies and methodologies could further enhance his research outputs. Engaging in interdisciplinary research may also yield innovative results.
Public Outreach and Dissemination:
- Increasing efforts in public outreach and science communication could enhance the societal impact of his research. Engaging with broader audiences may help in promoting the importance of biotechnology.

Education

Davood Zare holds a B.Sc. in Microbiology (1993) and an M.Sc. in Bacteriology (1996) from Tehran University and Pasteur Institute of Iran, respectively. He earned his PhD in Food Biotechnology from University Putra Malaysia in 2013. His academic journey is characterized by a rigorous focus on microbiological research, culminating in significant contributions to both theoretical and practical aspects of the discipline. His education has laid a robust foundation for his subsequent research and teaching endeavors, enabling him to bridge academic knowledge with real-world applications in biotechnology.

Experience

Davood Zare has extensive experience in research and leadership within biotechnology. He has worked as an executive and assistant researcher on various projects at IROST since 1994, focusing on microbial production and bioprocess optimization. He has also held leadership roles, including Head of Biotechnology Pilot Plant and Deputy of the Department of Biotechnology. His teaching experience spans multiple institutions, where he has educated both M.Sc. and Ph.D. students in subjects like Industrial Microbiology and Biotechnology. Davood’s comprehensive experience equips him to address complex challenges in the field of food biotechnology effectively.

Research Focus

Davood Zare’s research focuses on food biotechnology, microbial production, and the optimization of bioprocesses. His work includes the production of microbial proteins, bioplastics, and bioactive compounds from various substrates. He is particularly interested in sustainable practices, utilizing waste materials for bioproduct production, and enhancing microbial fermentation processes. His contributions have significant implications for food safety, quality, and sustainability, making him a key player in advancing biotechnological applications in the food industry.

Publication Top Notes

Production of xylanase by Trichoderma longibrachiatum on a mixture of wheat bran and wheat straw: optimization of culture condition by Taguchi method
Trans-and cis-urocanic acid, biogenic amine and amino acid contents in ikan pekasam (fermented fish) produced from Javanese carp (Puntius gonionotus) and black tilapia
Changes in urocanic acid, histamine, putrescine and cadaverine levels in Indian mackerel (Rastrelliger kanagurta) during storage at different temperatures
Assessing the quality of sardine based on biogenic amines using a fuzzy logic model
Determination of urocanic acid, a compound implicated in histamine toxicity, and assessment of biogenic amines relative to urocanic acid content in selected fish and fish products
Screening of carbon and nitrogen sources using mixture analysis designs for carotenoid production by Blakeslea trispora
Production and characterization of poly 3-hydroxybutyrate-co-3-hydroxyvalerate in wheat starch wastewater and its potential for nanoparticle synthesis
Determination of trans‐ and cis‐Urocanic Acid in Relation to Histamine, Putrescine, and Cadaverine Contents in Tuna (Auxis Thazard) at Different Storage
Hydrogen sulfide removal performance of a bio-trickling filter employing Thiobacillus thiparus immobilized on polyurethane foam under various starvation regimes
Synthesis, in vitro and cellular antioxidant activity evaluation of novel peptides derived from Saccharomyces cerevisiae protein hydrolysate: structure–function
Development and validation of an ion-pair chromatographic method for simultaneous determination of trans-and cis-urocanic acid in fish samples
Isolation, screening and medium optimization of native microalgae for lipid production using nutritional starvation strategy and statistical design
Organic acid composition and consumer acceptability of fermented fish produced from black tilapia (Oreochromis mossambicus) and Javanese carp (Puntius gonionotus) using natural
Single cell protein production using airlift reactor containing static mixer
Production of a mixed fruit juice powder using mixture analysis and a fuzzy model
Evaluation of the Physicochemical Characteristics of a Blend Fruit Juice Powder Mixed with Lactiplantibacillus plantarum: A Comparison of Spray Drying and
Evaluating the effect of microbial stimulation and oxidative stress on increasing β-Carotene production in Blakeslea trispora

Conclusion

Dr. Davood Zare is an exemplary candidate for the Best Researcher Award. His extensive educational background, rich research experience, and significant contributions to the field of biotechnology, combined with his leadership roles and teaching experience, position him as a leading figure in his area. By addressing areas for improvement, particularly in collaboration and public engagement, he can further enhance his impact and recognition in the scientific community. His work not only advances scientific knowledge but also has practical implications for industries related to food and biotechnology.

Baiju G Nair | Tissue engineering Award | Best Researcher Award

Posted on 06/07/202406/07/2024 by sciencefatherLeave a Comment

Assoc Prof Dr Baiju G Nair | Tissue engineering Award | Best Researcher Award

Assoc Prof Dr Baiju G Nair, National Institute if technology , India

Dr. Baiju G Nair is an esteemed researcher and educator specializing in Tissue Engineering, 4D Bioprinting, and Bio-Nanotechnology. Holding a Doctorate in Bio-Nano Science Fusion Technology from Toyo University, Japan, he has made significant contributions to biomaterials and tissue regeneration. With a rich academic background from University of Calicut, India, and extensive postdoctoral experience at Riken, Japan, Dr. Nair currently serves as Associate Professor and Head of the Department of Bioscience and Engineering at NIT Calicut. His research spans nanostructures, stem cell manipulation, and advanced biomaterials for medical applications.

Publication Profile

orcid

Education 📚

Dr. Baiju G Nair’s academic journey is marked by a profound commitment to scientific excellence. He earned his Doctor of Engineering in Bio-Nano Science Fusion Technology on a prestigious fellowship from the Ministry of Education, Society, Culture, and Sports (MEXT) in Japan. This advanced study was conducted at the Bio-Nano Electronics Research Centre within Toyo University’s Graduate School of New Inter-Disciplinary Sciences. Prior to this, he achieved a Master of Science in Microbial Biotechnology at the University of Calicut, Kerala, India, where he distinguished himself with top honors for academic performance and research. His foundation includes a Bachelor of Science in Zoology, Botany, and Chemistry from the same esteemed institution.

Experience

Dr. Baiju G Nair’s career is defined by a wealth of research, teaching, and administrative accomplishments. His postdoctoral experience spans prestigious roles such as SPDR Fellow and JSPS Foreign Postdoctoral Fellow at Riken’s Nanomedical Engineering Laboratory, and as a Postdoctoral Fellow at Toyo University’s BNERC. His research portfolio includes pioneering work in 3D & 4-D bioprinting, self-assembled nanostructures of proteins, RNA, and DNA, and innovative approaches in biomaterials and tissue engineering. As an educator, he has held key positions at NIT Calicut and Toyo University, fostering academic excellence. His administrative leadership includes roles as Head of Department, Vice Chairperson of CIRFL, and Innovation Ambassador, reflecting his commitment to academic and international collaborations.

Awards and Honors

Dr. Baiju G Nair’s illustrious career is adorned with prestigious awards and accolades. Notable among them are the BRIDGE JSPS Fellowship in 2022, the Young Scientist Award at the Biomedical Engineering Forum in 2017 held in Tsukuba, Japan, and the esteemed SPDR grant at Riken, Japan. His academic journey shines with distinctions such as the JSPS Foreign Postdoctoral Fellowship in 2012 and the Monbugakasho Fellowship from MEXT in 2008. His prowess in research was recognized globally with the Best Poster Presentation at NANOCON2011 in Brno, Czech Republic. Additionally, he secured the University Topper position with a Gold Medal and Rank during his master’s studies.

Research Focus

Dr. Baiju G. Nair specializes in nanotechnology platforms for biomedical applications, focusing on advanced drug delivery systems and nanostructured materials. His research spans diverse areas including 3D bioprinting, self-assembled nanostructures, and biomaterials for tissue engineering. Dr. Nair’s contributions also extend to nanomedicine innovations such as magnetic nanoparticle-based cancer therapies and nanostructured polymers for gene silencing. His expertise in nanoparticle synthesis and functionalization enhances targeted drug delivery and diagnostic tools. As a leader in the field, he continues to explore novel applications of nanotechnology in healthcare, pushing the boundaries of biomedical engineering.